In contrast, indirect mechanisms involve GM metabolites [21]; in fact, many metabolites, particularly short-chain fatty acids (SCFAs), bile acids (BAs), and intestinal hormones such as glucose-dependent insulinotropic peptide and glucagon-like peptide-1 (GLP-1), have been implicated as indirect agents in the development and progression of liver diseases. The gene discussed is GCG; the disease is liver disorder.